The heart of cardiac reprogramming: The cardiac fibroblasts
Cardiovascular disease is the leading cause of death worldwide, outpacing pulmonary disease, infectious disease, and all forms of cancer. Myocardial infarction (MI) dominates cardiovascular disease, contributing to four out of five cardiovascular related deaths. Following MI, patients suffer adverse and irreversible myocardial remodeling associated with cardiomyocyte loss and infiltration of fibrotic scar tissue. Current therapies following MI only mitigate the cardiac physiological decline rather than restore damaged myocardium function.
Source: Journal of Molecular and Cellular Cardiology - Category: Cytology Authors: Shea N. Ricketts, Li Qian Tags: Review article Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cytology | Heart | Heart Attack | Infectious Diseases